Abstract:Background: Type 2 diabetes (T2D) has an immense disease burden, affecting millions of people worldwide and costing billions of dollars in treatment. As T2D is a multifactorial disease with both genetic and nongenetic influences, accurate risk assessments for patients are difficult to perform. Machine learning has served as a useful tool in T2D risk prediction, as it can analyze and detect patterns in large and complex data sets like that of RNA sequencing. However, before machine learning can be implemented, feature selection is a necessary step to reduce the dimensionality in high-dimensional data and optimize modeling results. Different combinations of feature selection methods and machine learning models have been used in studies reporting disease predictions and classifications with high accuracy. Objective: The purpose of this study was to assess the use of feature selection and classification approaches that integrate different data types to predict weight loss for the prevention of T2D. Methods: The data of 56 participants (ie, demographic and clinical factors, dietary scores, step counts, and transcriptomics) were obtained from a previously completed randomized clinical trial adaptation of the Diabetes Prevention Program study. Feature selection methods were used to select for subsets of transcripts to be used in the selected classification approaches: support vector machine, logistic regression, decision trees, random forest, and extremely randomized decision trees (extra-trees). Data types were included in different classification approaches in an additive manner to assess model performance for the prediction of weight loss. Results: Average waist and hip circumference were found to be different between those who exhibited weight loss and those who did not exhibit weight loss ( P =.02 and P =.04, respectively). The incorporation of dietary and step count data did not improve modeling performance compared to classifiers that included only demographic and clinical data. Optimal subsets of transcripts identified through feature selection yielded higher prediction accuracy than when all available transcripts were included. After comparison of different feature selection methods and classifiers, DESeq2 as a feature selection method and an extra-trees classifier with and without ensemble learning provided the most optimal results, as defined by differences in training and testing accuracy, cross-validated area under the curve, and other factors. We identified 5 genes in two or more of the feature selection subsets (ie, CDP-diacylglycerol-inositol 3-phosphatidyltransferase [ CDIPT ], mannose receptor C type 2 [ MRC2 ], PAT1 homolog 2 [ PATL2 ], regulatory factor X-associated ankyrin containing protein [ RFXANK ], and small ubiquitin like modifier 3 [ SUMO3 ]). Conclusions: Our results suggest that the inclusion of transcriptomic data in classification approaches for prediction has the potential to improve weight loss prediction models. Identification of which individuals are likely to respond to interventions for weight loss may help to prevent incident T2D. Out of the 5 genes identified as optimal predictors, 3 (ie, CDIPT , MRC2 , and SUMO3 ) have been previously shown to be associated with T2D or obesity. Trial Registration: ClinicalTrials.gov NCT02278939; https://clinicaltrials.gov/ct2/show/NCT02278939

Subclassification of obesity for precision prediction of cardiometabolic diseases

Machine learning‐based clustering identifies obesity subgroups with differential multi‐omics profiles and metabolic patterns

Machine Learning to Identify Metabolic Subtypes of Obesity: A Multi-Center Study

Subtyping patients with chronic disease using longitudinal BMI patterns

244-LB: Data-Driven Metabolic Subgrouping of Obesity by Machine Learning (ML)

Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis

Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation

Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts

1252-P: Differences in Cardiometabolic and Immune Biomarkers between Novel Subphenotypes of Individuals at Elevated Risk for Type 2 Diabetes

Ambulatory Blood Pressure Monitoring for Risk Stratification in Obese and Non-Obese Subjects from 10 Populations.

Novel subgroups of obesity and their association with outcomes: a data-driven cluster analysis

Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference

Abstract EP02: Identification Of Genetic Signals For “Diabesity” --- Type 2 Diabetes And Obesity -- Among African American And European American Participants In Four Cohorts Of The TOPMed Consortium

IDF21-0141 Novel Clusters of Type 2 Diabetes and Their Association with Diabetic Retinopathy: a 3-year follow-up study

Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohort

Exploring New Tools for Risk Classification among Adults with Several Degrees of Obesity

Data-driven Subgroups of Prediabetes and the Associations with Outcomes in Chinese Adults.

EXIST: EXamining rIsk of excesS adiposiTy-Machine learning to predict obesity-related complications

Identification of Novel Metabolic Subtypes Using Multi-Trait Limited Mixed Regression in the Chinese Population

Prediction of Weight Loss to Decrease the Risk for Type 2 Diabetes Using Multidimensional Data in Filipino Americans: Secondary Analysis

Identifying subgroups of childhood obesity by using multiplatform metabotyping